This research is still at an early stage, and clinical uses are not in development yet, so if it does reach patients it will ...

Respiratory illnesses in chickens often come with other symptoms, including sneezing, coughing, wheezing, nasal discharge, or ...

Researchers have demonstrated that inebilizumab reduced the risk of symptoms by 87 percent in patients with the rare affliction known as immunoglobulin G4-related disease (IgG4-RD).

InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, today announced that the Committee for Medicinal Products for Human ...